InvestorsHub Logo
Followers 17
Posts 2671
Boards Moderated 0
Alias Born 06/04/2020

Re: None

Monday, 04/11/2022 8:38:18 AM

Monday, April 11, 2022 8:38:18 AM

Post# of 4271
'Veru (VERU) – The drugmaker’s shares surged 24.8% in the premarket after it reported “overwhelming” evidence of efficacy for its experimental drug for treating hospitalized Covid-19 patients. It will meet with the Food and Drug Administration to seek emergency use authorization for the treatment.'

https://www.cnbc.com/2022/04/11/stocks-making-the-biggest-moves-in-the-premarket-nio-veru-sailpoint-technologies-and-more.html

'MIAMI, April 11, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company, today announced positive efficacy and safety results from a planned interim analysis of the double-blind, randomized, placebo-controlled Phase 3 COVID-19 clinical trial evaluating oral sabizabulin 9 mg versus placebo in 150 hospitalized COVID-19 patients at high risk for Acute Respiratory Distress Syndrome (ARDS). The Independent Data Safety Monitoring Committee unanimously recommended that the Phase 3 study be halted early due to efficacy, and they further remarked that no safety concerns were identified.'

https://verupharma.com/news/verus-novel-covid-19-drug-candidate-reduces-deaths-by-55-in-hospitalized-patients-in-interim-analysis-of-phase-3-study-independent-data-monitoring-committee-halts-study-early-for-overwhelmin/

Bueller? Buller? Tempol? What a joke!

Rolling Stones are old and they suck!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADMP News